In a non‑diabetic patient with a normal monofilament test who presents with burning pain on the dorsal foot and upper calf, can herpes zoster (shingles) occur without a rash, and what is the typical duration of the episode with and without antiviral treatment?

Herpes Zoster Without Rash (Zoster Sine Herpete) in Non-Diabetic Patients

Yes, herpes zoster can absolutely occur without a rash—a condition called zoster sine herpete (ZSH)—and this should be strongly considered in your patient with burning pain on the dorsal foot and upper calf, especially given the normal monofilament test ruling out diabetic neuropathy.

Can Shingles Occur Without a Rash?

ZSH is a well-documented but frequently missed diagnosis where varicella-zoster virus (VZV) reactivates and causes dermatomal neuropathic pain without the characteristic vesicular eruption 1, 2. The pain typically follows a dermatomal distribution and may include burning sensations, allodynia, and hyperesthesia—exactly what your patient is experiencing 3.

Key diagnostic features to look for:

• Unilateral dermatomal pain pattern (burning, sharp, or needle-like)
• Pain that may precede any rash by days or never develop a rash at all
• Allodynia (pain from normally non-painful stimuli) in the affected dermatome
• No objective neurological deficits on examination 4

Critical pitfall: ZSH is often misdiagnosed as musculoskeletal pain or radiculopathy, particularly when imaging shows incidental degenerative changes 4. The dermatomal distribution of pain is your key diagnostic clue.

Confirming the Diagnosis

You must obtain laboratory confirmation since the absence of rash makes clinical diagnosis impossible:

• VZV IgM and IgG serology (positive in ZSH) 5
• VZV DNA PCR from blood if available (may be positive, particularly early in disease) 1, 2
• If neurological symptoms develop: CSF analysis with VZV DNA PCR 5, 6, 7

Research shows VZV DNA persists longer in serum of ZSH patients compared to typical herpes zoster (statistically significant at 1 month, P = 0.0007) 1.

Duration and Course

Without Antiviral Treatment:

The natural course is poorly defined but typically more severe and prolonged than typical herpes zoster. Studies demonstrate:

• Greater pain severity in ZSH versus typical HZ (VAS score 76.88 vs 66.88, P = 0.0012) 1
• Longer duration of pain compared to rash-associated zoster 1
• Higher risk of complications including encephalitis, vasculopathy, and postherpetic neuralgia without treatment 3, 5

With Antiviral Treatment:

Immediate antiviral therapy is essential and dramatically alters the course 8, 9:

For immunocompetent patients:

• Oral antivirals (famciclovir or valacyclovir) typically result in symptom resolution within days to 2 weeks 5
• New lesion formation (if rash develops later) ceases within 2 days of treatment 4
• Treatment duration: 7-10 days for uncomplicated cases

For any signs of CNS involvement or severe disease:

• Intravenous acyclovir is mandatory 9, 5, 6, 7
• Treatment duration: 14-21 days for meningitis/encephalitis 5, 7
• Clinical improvement typically seen within 48-72 hours of IV therapy

Treatment Recommendations

Start antiviral therapy immediately if clinical suspicion is high—do not wait for laboratory confirmation 9. The 2014 IDSA guidelines emphasize that herpes zoster pain often precedes skin findings by 24-72 hours (and sometimes longer), and early treatment prevents complications 9.

Specific regimens for immunocompetent adults:

• Famciclovir 500 mg three times daily for 7 days, OR
• Valacyclovir 1000 mg three times daily for 7 days, OR
• Acyclovir 800 mg five times daily for 7-10 days (less convenient dosing)

Pain management:

• Gabapentin (titrate to 1800-3600 mg/day divided) or pregabalin (150-600 mg/day divided) for neuropathic pain 10
• Avoid opioids as first-line; reserve for refractory cases 10

Critical Warning Signs Requiring Immediate Escalation

Seek immediate specialist consultation and consider IV acyclovir if:

• Severe headache develops (possible meningitis) 5, 6, 7
• Confusion or altered mental status (possible encephalitis) 6
• Focal neurological deficits emerge
• Pain involves cranial dermatomes (risk of ophthalmicus or CNS involvement)

Post-Herpetic Neuralgia Risk

Approximately 10-15% of patients develop post-herpetic neuralgia (PHN) after herpes zoster 8. Early antiviral treatment reduces this risk significantly. If PHN develops (pain persisting >3 months), treatment options include tricyclic antidepressants (NNT 2.64), gabapentin (NNT 4.39), or pregabalin (NNT 4.93) 10.

Bottom line: Your non-diabetic patient with dermatomal burning pain and normal monofilament test should be empirically treated for possible ZSH while awaiting VZV serologies. The condition typically resolves within 1-2 weeks with appropriate antiviral therapy, but untreated cases have prolonged courses with higher complication rates.